The  EU  Committee for Medicinal Products for Human Use (CHMP) has recently  considered  the  available  evidence  for an interaction between  clopidogrel  and  proton  pump  inhibitors  (PPIs).  They concluded  that  PPIs  reduce  the effectiveness of clopidogrel in preventing  the recurrence of adverse cardiac events such as heart attack  and  coronary artery restenosis (renarrowing of the artery [...]

Continue reading about Interactions between the use of clopidogrel and proton pump inhibitors

Dott. Luigi Vicari on febbraio 27th, 2009

Disponibile un prontuario farmaceutico aggiornato al 26/02/2009. Prontuario Farmaci del SSN aggiornato al 26-02-2009

Continue reading about Prontuario Farmaci del SSN

Dott. Luigi Vicari on agosto 1st, 2008


Continue reading about Farmaci